Manam Rama Rao, Teisan Sy, White Donald J, Nicholson Benjamin, Grodberg Jennifer, Neuteboom Saskia T C, Lam Kin S, Mosca Deborah A, Lloyd G Kenneth, Potts Barbara C M
Nereus Pharmaceuticals Inc., 10480 Wateridge Circle, San Diego, CA 92121, USA.
J Nat Prod. 2005 Feb;68(2):240-3. doi: 10.1021/np049725x.
A strain of Streptomyces nodosus (NPS007994) isolated from a marine sediment collected in Scripps Canyon, La Jolla, California, was found to produce lajollamycin (1), a nitro-tetraene spiro-beta-lactone-gamma-lactam antibiotic. The structure was established by complete analysis of spectroscopic data and comparison with known antibiotics oxazolomycin (2), 16-methyloxazolomycin (3), and triedimycin B (4). Lajollamycin (1) showed antimicrobial activity against both drug-sensitive and -resistant Gram-positive bacteria and inhibited the growth of B16-F10 tumor cells in vitro.
从加利福尼亚州拉霍亚市斯克里普斯峡谷采集的海洋沉积物中分离出的一株诺卡氏链霉菌(NPS007994),被发现可产生拉霍亚霉素(1),一种硝基四烯螺β-内酯-γ-内酰胺抗生素。通过对光谱数据的全面分析并与已知抗生素恶唑霉素(2)、16-甲基恶唑霉素(3)和三杀霉素B(4)进行比较,确定了其结构。拉霍亚霉素(1)对药物敏感和耐药的革兰氏阳性菌均显示出抗菌活性,并在体外抑制了B16-F10肿瘤细胞的生长。